Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Short-term Investments (2021 - 2022)

Historic Short-term Investments for Bioventus (BVS) over the last 2 years, with Q4 2022 value amounting to $23000.0.

  • Bioventus' Short-term Investments fell 9956.44% to $23000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $23000.0, marking a year-over-year decrease of 9956.44%. This contributed to the annual value of $23000.0 for FY2022, which is 9956.44% down from last year.
  • Per Bioventus' latest filing, its Short-term Investments stood at $23000.0 for Q4 2022, which was down 9956.44% from $23000.0 recorded in Q4 2022.
  • In the past 5 years, Bioventus' Short-term Investments registered a high of $5.3 million during Q4 2021, and its lowest value of $23000.0 during Q4 2022.